Provided by Tiger Trade Technology Pte. Ltd.

Orchestra BioMed

4.95
+0.05001.02%
Post-market: 4.950.00000.00%16:10 EDT
Volume:240.38K
Turnover:1.18M
Market Cap:296.41M
PE:-4.95
High:5.01
Open:4.92
Low:4.83
Close:4.90
52wk High:5.78
52wk Low:2.20
Shares:59.88M
Float Shares:33.00M
Volume Ratio:0.96
T/O Rate:0.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9995
EPS(LYR):-1.1091
ROE:-397.30%
ROA:-45.73%
PB:15.34
PE(LYR):-4.46

Loading ...

Orchestra BioMed COO, Director Darren Sherman Disposes of 15,000 Common Shares for $74,100

Reuters
·
1 hour ago

Orchestra BioMed Grants 133,000 Inducement Stock Options to Seven New Hires Under 2025 Plan

Reuters
·
1 hour ago

Orchestra Biomed Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
1 hour ago

Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
1 hour ago

Orchestra BioMed COO Darren Sherman Reports Acquisition of 2,000 Common Shares Valued at $10,660

Reuters
·
Aug 29

Orchestra BioMed CEO Hochman Presents at H.C. Wainwright Global Investment Conference

Reuters
·
Aug 27

Orchestra BioMed CEO Hochman Presents at Wells Fargo Healthcare Conference

Reuters
·
Aug 20

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Simply Wall St.
·
Aug 13

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 13

Stereotaxis Q2 Revenue Misses Estimates, Dragged by System Decline

Reuters
·
Aug 12

Orchestra BioMed price target raised to $10 from $9 at Piper Sandler

TIPRANKS
·
Aug 11

Orchestra BioMed Holdings (OBIO) Receives a Buy from Piper Sandler

TIPRANKS
·
Aug 11

Orchestra Biomed Holdings Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 11

Orchestra BioMed Hldgs Q2 EPS $(0.38) Misses $(0.37) Estimate, Sales $88.000K Miss $121.400K Estimate

Benzinga Earnings
·
Aug 11

Orchestra BioMed reports Q2 EPS (37c), consensus (38c)

TIPRANKS
·
Aug 11

Top News Today/Canada: Barrick Settles Newmont Dispute, Clearing Way to List Its Gold Assets

Dow Jones
·
Aug 11

Orchestra BioMed Q2 EPS USD -0.38

Reuters
·
Aug 11

Orchestra BioMed Q2 FY26 Net Loss Widens 23% to $24.1 Million; Revenue Drops to $88,000

Reuters
·
Aug 11

Orchestra Biomed Q2 Net Income USD -24.1 Million

THOMSON REUTERS
·
Aug 11

Press Release: Orchestra BioMed Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates

Dow Jones
·
Aug 11